Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study
2017 · The Lancet Oncology · 504 citations
https://doi.org/10.1016/s1470-2045(17)30243-7
D
Debbie Hicks
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
115
Papers
3.0K
Citations
22
h-index
32
i10-index
Debbie Hicks is an academic researcher from Newcastle University. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Muscle Physiology and Disorders & Cancer Genomics and Diagnostics. The author has an h-index of 22, co-authored 98 publications.
ORCID: 0000-0002-7551-7464Papers by this author
worksSecond-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes
2019 · Acta Neuropathologica · 292 citations
https://doi.org/10.1007/s00401-019-02020-0
Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunity
2020 · Nature Communications · 227 citations
https://doi.org/10.1038/s41467-020-18070-y
Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar development
2022 · Cell Reports · 72 citations
https://doi.org/10.1016/j.celrep.2022.111162
Exome sequences versus sequential gene testing in the UK highly specialised Service for Limb Girdle Muscular Dystrophy
2017 · Orphanet Journal of Rare Diseases · 54 citations
https://doi.org/10.1186/s13023-017-0699-9
Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification
2023 · Acta Neuropathologica · 12 citations
https://doi.org/10.1007/s00401-023-02566-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat